Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-051163
Filing Date
2008-09-04
Accepted
2008-09-04 12:11:36
Documents
1
Period of Report
2008-08-27

Document Format Files

Seq Description Document Type Size
1 v125173_ex.html 3  
1 v125173_ex.xml 3 3496
  Complete submission text file 0001144204-08-051163.txt   5277
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD, 711 EXECUTIVE BLVD., SUI NY 10989
Business Address 8452670707
WEINER BEN-ZION (Reporting) CIK: 0001444400 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51310 | Film No.: 081055769